Correction MAR label: Axel Schörling has, in accordance with the plan, started as new CEO in EQL Pharma AB and Martin Kristoffersson is appointed new COO.
The correction regards MAR label. This press release should not have a MAR label. Christer Fåhraeus, Founder & CEO, notified the Board in the autumn of 2021 that he intends to transition into a Board position after the Annual General Meeting (“AGM”) in August 2022. At that time, the Board appointed Axel Schörling, Deputy CEO, as new CEO after Fåhraeus´ resignation following the AGM in August 2022. After todays AGM, Schörling has assumed the position as new CEO in EQL. In connection with this, Martin Kristofferson, previously Director Strategic Sourcing, has been appointed new COO.